Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Patrick Wingrove

‘Shock’ as study reveals how weight-loss pill stacks up against injections

Eli Lilly’s experimental weight-loss pill delivered a 12.4 per cent body weight reduction in patients over 72 weeks, the pharmaceutical giant announced on Thursday.

However, the late-stage study results fell short of Novo Nordisk’s injectable Wegovy, which delivered 14.9 per cent weight loss over 68 weeks in a 2021 trial.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.